Blog by Rayyan Zafar, Mark Sweeney, Orla Mallon, Research Postgraduates in the Department of Brain Sciences and Institute of Clinical Sciences
Psychedelic drugs, such as psilocybin, ketamine, DMT and LSD are the subject of increasing research as potential novel treatments for addiction. Some of the most innovative work is being conducted by researchers in the UK.
My colleagues and I organised the first colloquium on psychedelics in addiction research, which took place in May 2024 at the Centre for Psychedelic Research at Imperial College London. The event provided a space for leading researchers in the field to meet, present their work and identify opportunities for future collaboration between institutions.